XERIS PHARMACEUTICALS Trademark

Trademark Overview

On Monday, May 15, 2017, a trademark application was filed for XERIS PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the XERIS PHARMACEUTICALS trademark a serial number of 87450239. The federal status of this trademark filing is REGISTERED as of Tuesday, May 19, 2020. This trademark is owned by Xeris Pharmaceuticals, Inc.. The XERIS PHARMACEUTICALS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of diseases and conditions, namely, metabolic and autoimmune diseases and conditions
xeris pharmaceuticals

General Information

Serial Number87450239
Word MarkXERIS PHARMACEUTICALS
Filing DateMonday, May 15, 2017
Status700 - REGISTERED
Status DateTuesday, May 19, 2020
Registration Number6059089
Registration DateTuesday, May 19, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 10, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of diseases and conditions, namely, metabolic and autoimmune diseases and conditions
Disclaimer with Predetermined Text"PHARMACEUTICALS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 19, 2017
Primary Code005
First Use Anywhere DateMonday, November 4, 2019
First Use In Commerce DateMonday, November 4, 2019

Trademark Owner History

Party NameXeris Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressChicago, IL 60601
Party NameXeris Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressChicago, IL 60601
Party NameXeris Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAustin, TX 78705

Trademark Events

Event DateEvent Description
Thursday, June 23, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Thursday, May 19, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Friday, May 22, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, May 22, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, May 22, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, May 22, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, May 22, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, May 19, 2020REGISTERED-PRINCIPAL REGISTER
Wednesday, April 15, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, April 14, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, April 14, 2020ASSIGNED TO EXAMINER
Saturday, March 28, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 27, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 27, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, December 13, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, December 13, 2019NON-FINAL ACTION E-MAILED
Friday, December 13, 2019SU - NON-FINAL ACTION - WRITTEN
Thursday, December 12, 2019STATEMENT OF USE PROCESSING COMPLETE
Thursday, December 5, 2019USE AMENDMENT FILED
Thursday, December 12, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, December 5, 2019TEAS STATEMENT OF USE RECEIVED
Thursday, June 6, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 4, 2019SOU EXTENSION 3 GRANTED
Tuesday, June 4, 2019SOU EXTENSION 3 FILED
Tuesday, June 4, 2019TEAS EXTENSION RECEIVED
Friday, November 2, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 31, 2018SOU EXTENSION 2 GRANTED
Wednesday, October 31, 2018SOU EXTENSION 2 FILED
Wednesday, October 31, 2018TEAS EXTENSION RECEIVED
Wednesday, June 27, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, June 27, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, May 31, 2018ASSIGNED TO EXAMINER
Saturday, May 12, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 10, 2018SOU EXTENSION 1 GRANTED
Thursday, May 10, 2018SOU EXTENSION 1 FILED
Thursday, May 10, 2018TEAS EXTENSION RECEIVED
Tuesday, December 5, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 10, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 10, 2017PUBLISHED FOR OPPOSITION
Wednesday, September 20, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 5, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, August 21, 2017EXAMINER'S AMENDMENT ENTERED
Monday, August 21, 2017ASSIGNED TO LIE
Monday, August 21, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, August 21, 2017EXAMINERS AMENDMENT E-MAILED
Monday, August 21, 2017EXAMINERS AMENDMENT -WRITTEN
Monday, August 14, 2017ASSIGNED TO EXAMINER
Friday, May 19, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, May 18, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

pharmaceuticals xeris conditions diseases metabolic autoimmune namely preparations pharmaceutical treatment